Lymphoma — Ann Arbor / Lugano

Ann Arbor stage with the Lugano 2014 modifications (Hodgkin and non-Hodgkin lymphoma)
Ann Arbor stage
Extranodal involvement
B symptoms (unexplained fever, drenching night sweats, or > 10% weight loss over 6 months)
Bulky disease (single mass ≥ 10 cm, or > 1/3 of the thoracic diameter)

About this score

When to use

Stages Hodgkin and non-Hodgkin lymphoma with the Lugano classification, which keeps the Ann Arbor stages I–IV with A/B and E designators. ⁦[1]⁩

Pearls and pitfalls

• The X (bulk) suffix is no longer used for staging, but bulk remains a prognostic factor; disease is grouped as limited (I–II, non-bulky) or advanced. ⁦[1]⁩
• PET-CT is the standard imaging for FDG-avid lymphomas, and the stage is combined with prognostic indices such as IPI, IPS or FLIPI. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Retained the Ann Arbor stages I–IV with A/B and E designators, removed routine use of the X (bulk) suffix for staging while keeping bulk as a prognostic factor, and defined limited (I–II non-bulky) versus advanced disease for treatment.
Journal of Clinical Oncology, 2014
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore